2017 - CIRTA


This page contains exclusive content for the member of the following sections: TTS, ITA. Log in to view.

4b- Intestinal Failure Outcomes - Neurocognitive and Disease Specific

33.1 - Neurodevelopmental outcomes of infants with intestinal failure at 12 and 26 months corrected age

Presenter: Stephanie, So, Toronto, Canada
Authors: Stephanie So, Anna Gold, Catherine Patterson, Alaine Rogers, Christina Belza, Nicole de Silva, Yaron Avitzur, Paul Wales

Neurodevelopmental outcomes of infants with intestinal failure at 12 and 26 months corrected age

Stephanie So1,3,7, Anna Gold2,3,7, Catherine Patterson1,3,7, Alaine Rogers1,3,7, Christina Belza3,7, Nicole de Silva4,7, Yaron Avitzur5,7, Paul W. Wales6,7.

1Department of Rehabilitation Services, The Hospital for Sick Children , Toronto, ON, Canada; 2Department of Psychology, The Hospital for Sick Children , Toronto, ON, Canada; 3Transplant and Regenerative Medicine Centre, The Hospital for Sick Children , Toronto, ON, Canada; 4Department of Neonatology, The Hospital for Sick Children , Toronto, ON, Canada; 5Division of Gastroenterology, Hepatology and Nutirition, The Hospital for Sick Children , Toronto, ON, Canada; 6Division of General and Thoracic Surgery, The Hospital for Sick Children , Toronto, ON, Canada; 7Group for Improvement of Intestinal Function and Treatment (GIFT), The Hospital for Sick Children , Toronto, ON, Canada

Purpose: Survival of infants with intestinal failure (IF) has improved, yet multiple medical factors may impact development. This study examines neurodevelopmental outcomes at 12-15 and 26-32 months corrected age in a cohort of children with IF.

Methods: Prospective single centre neurodevelopmental assessments of children admitted to an intestinal rehabilitation program between 2011-2014. Outcome measures include: Mullen Scales of Early Learning (12 and 26 months) and Vineland-II Adaptive Behaviour Scales (26 months). Standard scores were correlated with medical and demographic factors.

Results: Thirty-one children (17 males), median gestational age 34 weeks (interquartile range (IQR) 30-36) with birth weight (BW) 2.12 kilograms (IQR 1.24-2.52). Ten (32.2%) were dependent on parental nutrition (PN) at the second assessment. At 12 months, 11/30 (36.7%) scored below average (>1 standard deviation below mean) on the Early Learning (EL) composite and 24/30 (80%) were below average on the Gross Motor (GM) subscale. Comparatively, at 26 months, mean EL scores were significantly lower, most notably in Visual Reception (VR) and Fine Motor (FM) subscales (p=.001). Mean GM scores remained low, and parents reported the lowest scores on the motor domain of the Vineland-II. 

At 12-15 months, factors significantly (p<.05) associated with lower scores are primarily related to prematurity: lower VR scores correlate with lower BW (r= -.469) and longer neonatal intensive care admission (r= -.384), while lower FM scores correlate with longer NICU (r= -.442) and hospital (r= -.431) admissions.

At 26-32 months, the impact of IF-related variables, over and above early neonatal influences are more apparent. There is a significant correlation between lower FM scores and longer hospital admissions (r= -.392), while lower GM scores correlate with shorter small bowel length (r= .393) and greater PN days (r= -.506). Total PN days remain significant even when adjusting for prematurity.  

Additional significant risk factors include: central nervous system co-morbidities, necrotizing enterocolitis etiology and history of sustained conjugated bilirubin.

Conclusion: Children with IF are at risk of developmental delay in multiple domains. While gross motor skills appear to be most significantly affected, early learning deficits become more apparent at >2 years of age, which could impact future school performance. Early developmental follow up and intervention are important for this population. 


Important Disclaimer

By viewing the material on this site you understand and accept that:

  1. The opinions and statements expressed on this site reflect the views of the author or authors and do not necessarily reflect those of The Transplantation Society and/or its Sections.
  2. The hosting of material on The Transplantation Society site does not signify endorsement of this material by The Transplantation Society and/or its Sections.
  3. The material is solely for educational purposes for qualified health care professionals.
  4. The Transplantation Society and/or its Sections are not liable for any decision made or action taken based on the information contained in the material on this site.
  5. The information cannot be used as a substitute for professional care.
  6. The information does not represent a standard of care.
  7. No physician-patient relationship is being established.

Social

Contact

Staff Directory
+1-514-874-1717
info@tts.org

Address

The Transplantation Society
International Headquarters
740 Notre-Dame Ouest
Suite 1245
Montréal, QC, H3C 3X6
Canada